MLAB vs BMI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 16, 2026
MLAB
BMI
Investment Advisor Scores
BMI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MLAB | BMI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 34.4828 | 26.178 | BMI |
| PEG Ratio | 0 | 3.0632 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 1.0% | -6.6% | MLAB |
| Earnings Growth | -42.4% | -12.8% | BMI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 52.7/100 | 56.2/100 | BMI |
| Profit Margin | 1.9% | 14.3% | BMI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MLAB
MarkupPrice above SMA50, rising 50-day trend (10.3% over 20 days), RSI 53
BMI
NeutralMixed signals - no dominant trend phase, RSI 56
Fundamentals Snapshot
| Metric | MLAB | BMI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 24.0 | 26.6 |
| Trailing P/E | 147.2 | 30.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | -0.1% |
| Gross Margin | 0.6% | 0.4% |
| Operating Margin | 0.1% | 0.2% |
| EPS | 0.85 | 4.28 |
| Dividend Yield | 0.01% | 0.01% |